Let’s start up with the current stock price of AnPac Bio-Medical Science Co. Ltd. (ANPC), which is $0.30 to be very precise. The Stock rose vividly during the last session to $0.34 after opening rate of $0.2709 while the lowest price it went was recorded $0.2535 before closing at $0.26.Recently in News on May 11, 2022, AnPac Bio Regains Compliance with Market-Value-Of-Publicly Held Shares Requirement upon Transfer to The Nasdaq Capital Market. AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that The Nasdaq Stock Market LLC (“Nasdaq) has notified the Company on May 9, 2022, that ANPC’s American Depositary Shares are now in compliance with the maintenance of the minimum market value of publicly held shares (“MVPHS”) of $1,000,000 as a result of the transfer of the Company’s securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Nasdaq Capital Market has lower listing requirements than those of The Nasdaq Global Market, while both are a part of The Nasdaq Stock Market. You can read further details here
AnPac Bio-Medical Science Co. Ltd. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.3500 on 01/04/22, with the lowest value was $0.2025 for the same time period, recorded on 05/09/22.
AnPac Bio-Medical Science Co. Ltd. (ANPC) full year performance was -93.01%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AnPac Bio-Medical Science Co. Ltd. shares are logging -94.70% during the 52-week period from high price, and 48.15% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.20 and $5.66.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1903400 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the AnPac Bio-Medical Science Co. Ltd. (ANPC) recorded performance in the market was -75.41%, having the revenues showcasing -66.94% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 5.45M, as it employees total of 86 workers.
Market experts do have their say about AnPac Bio-Medical Science Co. Ltd. (ANPC)
During the last month, 0 analysts gave the AnPac Bio-Medical Science Co. Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.7064, with a change in the price was noted -0.82. In a similar fashion, AnPac Bio-Medical Science Co. Ltd. posted a movement of -73.21% for the period of last 100 days, recording 917,501 in trading volumes.
Technical breakdown of AnPac Bio-Medical Science Co. Ltd. (ANPC)
Raw Stochastic average of AnPac Bio-Medical Science Co. Ltd. in the period of last 50 days is set at 14.39%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 30.71%. In the last 20 days, the company’s Stochastic %K was 22.19% and its Stochastic %D was recorded 18.77%.
Bearing in mind the latest performance of AnPac Bio-Medical Science Co. Ltd., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -75.41%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -87.80%, alongside a downfall of -93.01% for the period of the last 12 months. The shares increased approximately by -13.92% in the 7-day charts and went up by -38.65% in the period of the last 30 days. Common stock shares were lifted by -66.94% during last recorded quarter.